Rankings
▼
Calendar
EVMN (Evommune, Inc.) Stock Financials & Earnings | Market Cap Arena
EVMN
Evommune, Inc.
Mkt Cap
$319M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NYSE
Revenue (TTM)
$13M
Net Income (TTM)
-$59M
EPS (TTM)
-$2.80
Free Cash Flow (TTM)
-$82M
Gross Margin
91.8%
Op. Margin
-541.1%
Net Margin
-453.2%
FCF Margin
-632.6%
P/S Ratio (TTM)
24.5x
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q3 2025
Browse All Reports
Next: Q4 2025 · Mar 26
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 24
$7M
$7M
-$4M
Q2 24
$0
-$325K
-$28M
Q4 24
$0
$0
-$19M
Q1 25
$3M
$3M
-$15M
Q2 25
$0
-$375K
-$23M
Q3 25
$10M
$10M
-$13M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 24
—
—
Q2 24
—
—
Q4 24
—
—
Q1 25
31.9x
—
Q2 25
106.3x
—
Q3 25
24.5x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 24
-$5M
-$5M
Q2 24
-$9M
-$9M
Q4 24
-$22M
-$22M
Q1 25
-$24M
-$24M
Q2 25
-$26M
-$26M
Q3 25
-$10M
-$10M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 24
$70K
Q2 24
$18K
Q4 24
$0
Q1 25
$0
Q2 25
$0
Q3 25
$131K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q2 25
-100.0%
+113.8%
Q3 25
—
-17.5%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 24
$0
0.0%
Q2 24
$0
—
Q4 24
$448K
—
Q1 25
$0
0.0%
Q2 25
$0
—
Q3 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
SG&A
Quarter
R&D
G&A
S&M
SG&A
Q1 24
$8M
—
—
$3M
Q2 24
$25M
—
—
$3M
Q4 24
$16M
$2M
$1M
—
Q1 25
$14M
—
—
$3M
Q2 25
$20M
$3M
—
—
Q3 25
$20M
—
—
$3M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q4 24
$16M
$56M
$72M
Q1 25
$6M
$43M
$48M
Q2 25
$62M
$25M
$87M
Q3 25
$27M
$49M
$76M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 24
30M
—
Q2 24
30M
+0.0%
Q4 24
13M
-56.8%
Q1 25
30M
+131.6%
Q2 25
30M
+0.0%
Q3 25
32M
+4.8%
marketcaparena.com